These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 29212806)

  • 1. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins.
    Ren Z; van Andel H; de Lau W; Hartholt RB; Maurice MM; Clevers H; Kersten MJ; Spaargaren M; Pals ST
    Blood; 2018 Mar; 131(9):982-994. PubMed ID: 29212806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins.
    van Andel H; Ren Z; Koopmans I; Joosten SP; Kocemba KA; de Lau W; Kersten MJ; de Bruin AM; Guikema JE; Clevers H; Spaargaren M; Pals ST
    Proc Natl Acad Sci U S A; 2017 Jan; 114(2):376-381. PubMed ID: 28028233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression.
    Nam JS; Turcotte TJ; Smith PF; Choi S; Yoon JK
    J Biol Chem; 2006 May; 281(19):13247-13257. PubMed ID: 16543246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling.
    Park S; Cui J; Yu W; Wu L; Carmon KS; Liu QJ
    J Biol Chem; 2018 Jun; 293(25):9759-9769. PubMed ID: 29752411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options.
    van Andel H; Kocemba KA; Spaargaren M; Pals ST
    Leukemia; 2019 May; 33(5):1063-1075. PubMed ID: 30770859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma.
    Reijmers RM; Groen RW; Rozemuller H; Kuil A; de Haan-Kramer A; Csikós T; Martens AC; Spaargaren M; Pals ST
    Blood; 2010 Jan; 115(3):601-4. PubMed ID: 19965677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor.
    Gong X; Carmon KS; Lin Q; Thomas A; Yi J; Liu Q
    PLoS One; 2012; 7(5):e37137. PubMed ID: 22615920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling.
    Carmon KS; Gong X; Lin Q; Thomas A; Liu Q
    Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11452-7. PubMed ID: 21693646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-4 inhibits Wnt/β-catenin signaling through regulation of low-density-lipoprotein receptor-related protein (LRP6) and R-spondin 3.
    Astudillo P; Carrasco H; Larraín J
    Int J Biochem Cell Biol; 2014 Jan; 46():103-12. PubMed ID: 24275095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/β-catenin pathway in skeletal myogenesis.
    Han XH; Jin YR; Tan L; Kosciuk T; Lee JS; Yoon JK
    Mol Cell Biol; 2014 Feb; 34(4):752-64. PubMed ID: 24344199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling.
    Glinka A; Dolde C; Kirsch N; Huang YL; Kazanskaya O; Ingelfinger D; Boutros M; Cruciat CM; Niehrs C
    EMBO Rep; 2011 Sep; 12(10):1055-61. PubMed ID: 21909076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Wnt/beta-catenin signalling in osteoclasts in multiple myeloma.
    Qiang YW; Chen Y; Brown N; Hu B; Epstein J; Barlogie B; Shaughnessy JD
    Br J Haematol; 2010 Mar; 148(5):726-38. PubMed ID: 19961481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LGR4 acts as a key receptor for R-spondin 2 to promote osteogenesis through Wnt signaling pathway.
    Zhu C; Zheng XF; Yang YH; Li B; Wang YR; Jiang SD; Jiang LS
    Cell Signal; 2016 Aug; 28(8):989-1000. PubMed ID: 27140682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein kinase 2 Is activated and essential for Wnt/beta-catenin signaling.
    Gao Y; Wang HY
    J Biol Chem; 2006 Jul; 281(27):18394-400. PubMed ID: 16672224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling.
    de Lau W; Barker N; Low TY; Koo BK; Li VS; Teunissen H; Kujala P; Haegebarth A; Peters PJ; van de Wetering M; Stange DE; van Es JE; Guardavaccaro D; Schasfoort RB; Mohri Y; Nishimori K; Mohammed S; Heck AJ; Clevers H
    Nature; 2011 Jul; 476(7360):293-7. PubMed ID: 21727895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. R-spondins can potentiate WNT signaling without LGRs.
    Lebensohn AM; Rohatgi R
    Elife; 2018 Feb; 7():. PubMed ID: 29405118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of R-spondins and their receptors in bone metabolism.
    Shi GX; Mao WW; Zheng XF; Jiang LS
    Prog Biophys Mol Biol; 2016 Nov; 122(2):93-100. PubMed ID: 27237581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-spondin 2 facilitates differentiation of proliferating chondrocytes into hypertrophic chondrocytes by enhancing Wnt/β-catenin signaling in endochondral ossification.
    Takegami Y; Ohkawara B; Ito M; Masuda A; Nakashima H; Ishiguro N; Ohno K
    Biochem Biophys Res Commun; 2016 Apr; 473(1):255-264. PubMed ID: 27012200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-equivalence of Wnt and R-spondin ligands during Lgr5
    Yan KS; Janda CY; Chang J; Zheng GXY; Larkin KA; Luca VC; Chia LA; Mah AT; Han A; Terry JM; Ootani A; Roelf K; Lee M; Yuan J; Li X; Bolen CR; Wilhelmy J; Davies PS; Ueno H; von Furstenberg RJ; Belgrader P; Ziraldo SB; Ordonez H; Henning SJ; Wong MH; Snyder MP; Weissman IL; Hsueh AJ; Mikkelsen TS; Garcia KC; Kuo CJ
    Nature; 2017 May; 545(7653):238-242. PubMed ID: 28467820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.